Presentation is loading. Please wait.

Presentation is loading. Please wait.

APAC - Agile FY10 Q3 Ops Review 30 th March,2010.

Similar presentations


Presentation on theme: "APAC - Agile FY10 Q3 Ops Review 30 th March,2010."— Presentation transcript:

1 APAC - Agile FY10 Q3 Ops Review 30 th March,2010

2 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED2 Agenda FY10 Q3 Highlights FY10 Q4 Highlights Q4 Pipe Q4 Budget and Status Q4 Top Deals Marketing Momentum Other Highlights

3 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED3 FY’10 Q2 Performance to Budget FY10 Budget and Actual FY’10 Q1 Performance to Budget FY’10 Q3 Performance to Budget

4 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED4  WINS  2 New Customers in Q3 across APAC  Chartered Semiconductor expanded Footprint to Global Foundries. Standardised their PLM Platform globally on Agile. Next phase of implementation is to replace PTC Q3 Highlights – Agile

5 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED5 New Customers Growth Q1- 8 Q2 - 5 Q3 - 2 15

6 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED6 FY10 – Q4 Status Top Deals in Progress Foxconn (1064 k) - Closed Ranbaxy – 200k Sanitorium – 200 k Huawei – 600 k Small deals to contribute 600 K from 11 opportunities Forecast for Q4 – 2,000 K Current Forecast will help us to achieve 86 % of the FY10 budget and 47 % growth over FY09.

7 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED7 Region 40 % Uncommit ted 40% to 59 % committed 60%+ Committed Total Pipe APAC 177939215653736 Q4 Pipe

8 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED8 15 Top Active Anchor Deals – Agile RegionQTRAccountTarget RevenueRemarks ASEAN Q2 CP Foods 300000 CLOSED ASEAN Q3 Chartered 291000 CLOSED China Q4 Foxconn 1064000 CLOSED IndiaQ4Ranbaxy 170000 Solution Phase ChinaQ4-UpsideHuawei (ULA) 600000 ULA being negotiated ANZQ4-UpsideResmed 170000 Still Upside. New CIO giving us tough time ANZ Q4-Upside Sanitarium 200000 POC engagement being negotiated ASEAN Q4-Upside IMI 200000 Early Value Assessment done Korea Q4 Samsung 100000 Pilot project under progress ANZFY11Simplot 250000 Part of Global deal. Commercials ANZFY11Coco Cola Amatil 200000 Early Sales cycle ASEANFY11AVIVA 150000 Orgnaisation going through major restructuring KOREAFY11LG Display 500000 POC need to be done again in Q4 IndiaFY11DRL 200000 Internal approval for the QBD project ChinaFY11Beijing Pharmaceuticals 200000 Q4 Upside HongkongFY11Mattel 300000 Global Opportunity APAC POC completed TaiwanFY11ASUS 200000

9 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED9 Targeted 1-1 Workshops – Highlights Named Accounts Pipe Development  ASEAN  Panasonic- Completed  CP Foods – Won  IMI - Completed  DEXA Pharmaceuticals - Completed  San Miguel – Planned in FY11  AVIVA - Completed  GC  Beijing Pharmaceuticals - Completed  Mattel - Completed  Catcher Technology- completed  Korea  Samsung C&T - Completed  Doosan Engines and Heavy Engg- Completed  Ildong Pharmaceuticals – Completed  ANZ  Sanitarium – ANZ- Waiting confirmation  INDIA  DRL - Global Workshop for EQM delivered  Ranbaxy - Completed and 3 years IT Roadmap being progressed

10 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED10 Manufacturing and PLM Summits in Major cities across APAC India : Delhi,Mumbai,Chennai China Marketing Events – Q3 APAC F&B Webcast for Food & Beverages ASEAN Semiconductor Conference in Singapore PLM series in Supply Chain and Manufacturing Summit CHINA Food & Beverages Technology Innovation Sponsorship – China Lead maturation events with Partner in 3 cities -China Marketing Events – Q4 Marketing Momentum

11 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED11 Other Highlights  CP Foods Implementation – Implementation issue being sorted out and Customer care driving with support from Edge team (Presales) and Development Team supporting Partners for 5 weeks implementation process  Pharmaceuticals Momentum :  Ranbaxy – Detailed Discovery session to assess PLM Solution for Generic Pharma conducted. Potential Q4 though SAP and Siemens in the game. Siemens playing their strength of integrating R&D systems ( with machine interface) directly with PLM  DRL : Global Quality Management workshop to a team of 100 people delivered. High potential account in FY11  Siemens targeting F&B and Pharma aggressively.We need to be cautious and building the right eco system is the critical success factor. Siemens working on building data model for F&B and Pharma  Need to package our GTM – Right GSI, Solution set, Business Case template, Branding, IBU/SC/Sales capability  FY11 plan started and identified potential Target accounts for Agile

12 CONFIDENTIAL – ORACLE HIGHLY RESTRICTED12 Q U E S T I O N S A N S W E R S


Download ppt "APAC - Agile FY10 Q3 Ops Review 30 th March,2010."

Similar presentations


Ads by Google